Waxman Seeks Phenylephrine NDAC Review; Cites Efficacy Concerns
This article was originally published in The Tan Sheet
Executive Summary
Rep. Henry Waxman (D-Calif.) is calling for an FDA advisory panel to reconsider the efficacy of the nasal decongestant phenylephrine and re-evaluate its status as a monograph ingredient